Seattle Children’s Hospital


Date of Award

10.16.2017

Program

Type 1 Diabetes, Prevent & Delay

Amount

$2,031,407

Term of Grant

33 months

Project Title

Development of antigen-specific enhanced T-reg therapy in T1D

Project Description

Funds support a work into a preclinical proof-of-principle for an engineered targeted Treg cell therapy to treat type 1 diabetes.